Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

128.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 139.50p
  • 52 Week Low: 96.00p
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 1,546
  • Market Cap: £134.11m
  • RiskGrade: 91
  • Beta: 0.04

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
22.00% above the market average22.00% above the market average22.00% above the market average22.00% above the market average22.00% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average
1yr Revenue Growth
55.19% below the market average55.19% below the market average55.19% below the market average55.19% below the market average55.19% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
13.78% below the market average13.78% below the market average13.78% below the market average13.78% below the market average13.78% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
1yr DPS Growth
1.64% above the market average1.64% above the market average1.64% above the market average1.64% above the market average1.64% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
57.06% below the market average57.06% below the market average57.06% below the market average57.06% below the market average57.06% below the market average
84% below the sector average84% below the sector average84% below the sector average84% below the sector average84% below the sector average
Price Book Ratio
21.02% below the market average21.02% below the market average21.02% below the market average21.02% below the market average21.02% below the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
42.69% below the market average42.69% below the market average42.69% below the market average42.69% below the market average42.69% below the market average
17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average
Price Chg 3m
28.36% above the market average28.36% above the market average28.36% above the market average28.36% above the market average28.36% above the market average
2.56% above the sector average2.56% above the sector average2.56% above the sector average2.56% above the sector average2.56% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
43.62% below the market average43.62% below the market average43.62% below the market average43.62% below the market average43.62% below the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average
Momentum 20
64.81% below the market average64.81% below the market average64.81% below the market average64.81% below the market average64.81% below the market average
63.16% below the sector average63.16% below the sector average63.16% below the sector average63.16% below the sector average63.16% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
18.74% below the market average18.74% below the market average18.74% below the market average18.74% below the market average18.74% below the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average
ROCE
74.91% above the market average74.91% above the market average74.91% above the market average74.91% above the market average74.91% above the market average
64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
20.09% above the market average20.09% above the market average20.09% above the market average20.09% above the market average20.09% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Forecast EPS
43.3% below the market average43.3% below the market average43.3% below the market average43.3% below the market average43.3% below the market average
22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
42.97% above the market average42.97% above the market average42.97% above the market average42.97% above the market average42.97% above the market average
51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average
Operating Profit Loss
23.26% above the market average23.26% above the market average23.26% above the market average23.26% above the market average23.26% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
29.88% above the market average29.88% above the market average29.88% above the market average29.88% above the market average29.88% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Cash
5.57% above the market average5.57% above the market average5.57% above the market average5.57% above the market average5.57% above the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
14.19% below the market average14.19% below the market average14.19% below the market average14.19% below the market average14.19% below the market average
7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
27.36% above the market average27.36% above the market average27.36% above the market average27.36% above the market average27.36% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 128.00p
Change Today -0.50p
% Change -0.39 %
52 Week High 139.50p
52 Week Low 96.00p
Volume 1,546
Shares Issued 104.77m
Market Cap £134.11m
Beta 0.04
RiskGrade 91

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
58.11% below the market average58.11% below the market average58.11% below the market average58.11% below the market average58.11% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
40.77% above the market average40.77% above the market average40.77% above the market average40.77% above the market average40.77% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
26.54% below the market average26.54% below the market average26.54% below the market average26.54% below the market average26.54% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Growth
31.09% below the market average31.09% below the market average31.09% below the market average31.09% below the market average31.09% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 18-Jun-2019

Time Volume / Share Price
12:12 1,546 @ 129.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page